Home
MacroGenics

MacroGenics Market Share Analysis for November 2025

Nasdaq: MGNX), , today announced that the Company's management will. Oct 31, 2023. MacroGenics Announces Date of Third Quarter 2023 Financial Results Conference Call.

Health

Domainmacrogenics.com

Year Founded2000

Employees201 - 500

Annual Revenue$100M - $200M

MacroGenics

MacroGenics (including company regionals)

macrogenics.com

See more website traffic and engagement information

MacroGenics Revenue up to November 2025 is 100M - 200M

revenue generated by MacroGenics top domains

MacroGenics top domains revenue over 3 years

Revenue for MacroGenics top domains

macrogenics.com100M - 200M

See more with Sales Intelligence

Total visits to MacroGenics's top domains

Understand MacroGenics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

macrogenics.com11.3K

See more with Sales Intelligence

Avg. visit duration in MacroGenics's top domains

Analyze MacroGenics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

macrogenics.com00:01:54

See more with Sales Intelligence

Avg. pageviews on MacroGenics's top domains

See how MacroGenics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

macrogenics.com2.93

See more with Sales Intelligence

MacroGenics top competitors by domain

Top similar sites in November 2025, ranked by their affinity

oncomed.comCompany NameOncoMed Pharmaceuticals, Inc.Employees51 - 200HQUnited States, California, Redwood CityAnnual revenue$25M - $50MTotal visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by MacroGenics

These are the website technologies, by industry, used by MacroGenics top domains

Widget (4)

Twemoji

Email Services (3)

GoDaddy Email

Advertising (2)

DoubleClick

Content Management System (2)

WordPress

More Technologies

10

See all

News & Signals from MacroGenics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsMacroGenics, Inc. attended event Goldman Sachs 46th Annual Global Healthcare Conference 2025 on Nov 13th '25.MacroGenics, Inc., a biopharmaceutical company specializing in antibody-based cancer therapies, announced that its President and CEO, Eric Risser, will participate in a fireside chat at the Stifel 2025 Healthcare Conference on November 13, 2025, at 4:00 pm ET in New York City.

NewsMacroGenics, Inc. attends event H.C. Wainwright 27th Annual Global Investment Conference.ROCKVILLE, MD, Sept. 02, 2025 (GLOBE NEWSWIRE) - MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that MacroGenics' President & Chief Executive Officer, Eric Risser, will present at the H.C. Wainwright 27th Annual Global Investment Conference on Monday, September 8, 2025, at 11:30am ET in New York, NY.

NewsMacroGenics, Inc. promotes Eric Risser to president and CEO.MacroGenics promotes Eric Risser to president and CEO.